ISARIC
  • Home
  • About
    • About
    • Hubs
    • Membership
    • People
  • Research
    • Research
    • Bubonic plague
    • COVID-19
    • Dengue
    • Ebola and other Filoviruses
    • H5Nx
    • Lassa fever
    • Nipah
    • Mpox
    • Severe Acute Hepatitis
  • Resources
    • Clinical Characterisation Protocol
    • Community Engagement
    • Core Outcome Sets
    • Current Opportunities
    • Data
    • Outputs
    • Resources
    • Stigma
  • Increasing Capacity
    • Increasing Capacity
    • CREDO
  • News & Events
    • News
    • Events
Select Page

Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation

by Wajeeha Malik | Aug 30, 2024

An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protoco

by Wajeeha Malik | Jul 5, 2024

Experiences and challenges with the new European Clinical Trials Regulation

by Wajeeha Malik | Jun 21, 2024

Community Involvement in an Outbreak—One Year on for Mpox

by Wajeeha Malik | Jun 21, 2024

Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials (Preprint)

by Wajeeha Malik | Jun 20, 2024

« Older Entries

Our Mission
Contact us
Opportunities
Funders
News

Follow ISARIC on X

Apply for membership
© ISARIC 2023 | Accessibility | Terms & Conditions | Site by Herd

Cookies Policy

Our Website uses cookies to improve your experience. Please visit our Cookies page for more information about cookies and how we use them.

Close